Muh Muh Muh My Corona (virus)

CNBC had Albert Bourla on for 45 minutes after the news came out. He's the CEO of Pfizer. As an aside, CNBC's health and science reporter, Meg Tirell, who is pretty young, deserves a huge raise for her work. Her working that beat paid dividends for them.

This is huge. 90+ percent is small pox level of immunity. It's as good as any vaccine can do. They need to figure out how long lasting the immunity is, but this is going to give us our lives back. The biology is fascinating. They decided to go with an RNA-based model, so the spike protein for the virus was produced synthetically from a gene sequence. The RNA then penetrates the outside of your cells and induces an immune response -- the early results showed that people's bodies were producing both B and T cells, which is a broad based response, which is VERY encouraging.

Just from the way Bourla was talking about it, this is not people getting overly exuberant. This is like once in 100 years scientific work, in terms of the positive effect it is likely going to have on people's lives -- giving us our lives back. It may be even better than he realizes, because the results -- between the vaccinated group and the placebo group -- were done blind and it is being administered independently so he has no access to the underlying data yet. That will help unravel things such as how lasting the immunity is, but from what they have been told so far, it could be VERY good.

People just need to be patient. They will have the safety data the FDA wants next week, but from what he is saying, the vaccine looks safe. They are manufacturing vaccine in three facilities in the U.S. and two in Europe, but it is a BIG world and to the extent people are willing to get vaccinated, it may not be available as quickly for a lot of us as some people would like.

But this passes the smell test of miracle vaccine so far.